Harpreet Singh

Dr. Harpreet Singh


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Family Medicine and Primary Care
Verified
Journal Article
Open access
PDF file
HSHarpreet Singh
Harpreet Singh
RKRelangi H S Krishna
Relangi H S Krishna
AJArihant Jain
Arihant Jain
NSNavneet Sharma
Navneet Sharma
Diabetic ketoacidosis is one of the most serious complications of diabetes mellitus. Role of bicarbonate therapy in severe diabetic ketoacidosis is controversial. There are only few case reports of management of refractory diabetic ketoacidosis with renal replacement therapy. Here, we present a case of young male with severe diabetic ketoacidosis, which was refractory to fluid resuscitation, insulin and was managed successfully managed with peritoneal dialysis.

21 April 2024 in The American Journal of Medicine
Verified
Journal Article
Closed access
VCVishali Chandrasekhar
Vishali Chandrasekhar
HSHarpreet Singh
Harpreet Singh
ASAravind Subramanian
Aravind Subramanian
DDDeba Prasad Dhibar
Deba Prasad Dhibar
VSVikas Suri
Vikas Suri
ABAshish Bhalla
Ashish Bhalla

29 March 2025 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
VMVinay Modgil
Vinay Modgil
NSNusrat Shafiq
Nusrat Shafiq
AGAmandeep Gondara
Amandeep Gondara
RSRashmi Surial
Rashmi Surial
HSHarpreet Singh
Harpreet Singh
Neelam TanejaNeelam Taneja
Neelam Taneja

10 August 2024 in Indian Journal of Critical Care Medicine
Verified
Journal Article
Open access
HSHarpreet Singh
Harpreet Singh
VSVikas Suri
Vikas Suri
KBKhusrav Bajan
Khusrav Bajan
BPBanani Poddar
Banani Poddar
AHAshit Hegde
Ashit Hegde
RGRavi Ghawat
Ravi Ghawat
Dengue is one of the commonest causes of undifferentiated acute febrile illness in India as well as South East Asia. Nearly two-fifths of the world population is at risk of infection, and nearly 96 million infections reported worldwide, it is a major cause of concern across the globe. The ISCCM leadership felt that there have been no new directives/guidelines except the MOH guidelines for the management of dengue fever since 2014. Under the auspices of the Indian Society of Critical Care Medicine (ISCCM), an expert group of 14 intensivists from across the country, was formed. The task force members formulated questions that needed to be answered. These questions were validated by the members of ISCCM attending research conclave 2023. All the members systematically searched PubMed, MEDLINE, and Science Direct for original articles on different aspects of dengue management between January 1, 2000, and July 1, 2023. From the collected articles, duplicates were removed. Based on the evidence collected, the expert group members prepared statements/answers to the questions. Since most of the evidence is of moderate to low quality, a consensus was generated amongst the members of the task force. Each statement was agreed upon by 70% of the task force. The statements presented in the article are consensus statements as answers to queries raised. Bhalla A, Singh H, Suri V, Yaddanapudi L, Poddar B, Ghawat R, et al. ISCCM Position Statement: Management of Severe Dengue in Intensive Care Unit. Indian J Crit Care Med 2024;28(S2):S42-S58.

1 July 2023 in Journal of Global Infectious Diseases
Verified
Journal Article
Open access
KDKrishna Divyashree
Krishna Divyashree
HSHarpreet Singh
Harpreet Singh
MPMayur Parkhi
Mayur Parkhi
IKIndrani Karmakar
Indrani Karmakar
MSMan Updesh Singh Sachdeva
Man Updesh Singh Sachdeva
ABAshish Bhalla
Ashish Bhalla
Hemophagocytic lymphohistiocytosis is usually considered a rapidly progressive fatal illness with poor outcomes. It is of two types: primary or familial and secondary. In patients with HIV, opportunistic infections are the secondary triggers of HLH. First line of management of infection associated HLH is treatment of the underlying infection. Here, we present a case of HLH in HIV infection due to disseminated histoplasmosis managed with liposomal amphotericin B, who required immunosuppressive therapy with intravenous immunoglobulin and dexamethasone due to nonresponse to primary therapy.

17 January 2022 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
NANavneet Arora
Navneet Arora
PBPrasanna Bhat
Prasanna Bhat
PGPriyansh Gupta
Priyansh Gupta
HSHarpreet Singh
Harpreet Singh